Atomistry » Sodium » PDB 3epz-3f9l » 3f66
Atomistry »
  Sodium »
    PDB 3epz-3f9l »
      3f66 »

Sodium in PDB 3f66: Human C-Met Kinase in Complex with Quinoxaline Inhibitor

Enzymatic activity of Human C-Met Kinase in Complex with Quinoxaline Inhibitor

All present enzymatic activity of Human C-Met Kinase in Complex with Quinoxaline Inhibitor:
2.7.10.1;

Protein crystallography data

The structure of Human C-Met Kinase in Complex with Quinoxaline Inhibitor, PDB code: 3f66 was solved by C.Meier, T.Ceska, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.00 / 1.40
Space group P 1
Cell size a, b, c (Å), α, β, γ (°) 47.377, 47.587, 75.600, 100.70, 103.62, 98.29
R / Rfree (%) 16.8 / 22.5

Other elements in 3f66:

The structure of Human C-Met Kinase in Complex with Quinoxaline Inhibitor also contains other interesting chemical elements:

Fluorine (F) 6 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor (pdb code 3f66). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor, PDB code: 3f66:

Sodium binding site 1 out of 1 in 3f66

Go back to Sodium Binding Sites List in 3f66
Sodium binding site 1 out of 1 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Na6

b:34.9
occ:1.00
O B:HOH289 2.2 31.7 1.0
O B:PHE1134 2.4 29.4 1.0
O B:HOH201 2.5 26.8 1.0
O B:HOH155 2.5 40.9 1.0
O B:LYS1132 2.6 31.3 1.0
O B:HOH280 2.7 45.3 1.0
C B:PHE1134 3.6 26.7 1.0
C B:LYS1132 3.7 28.9 1.0
CB B:SER1135 4.2 28.1 1.0
NZ B:LYS1132 4.2 36.0 1.0
O B:MET1131 4.3 32.2 1.0
N B:PHE1134 4.4 27.5 1.0
O B:HOH30 4.4 27.3 1.0
CA B:SER1135 4.4 26.3 1.0
CA B:LYS1132 4.4 31.5 1.0
OG B:SER1141 4.5 19.7 0.5
CB B:SER1141 4.5 24.7 0.5
N B:SER1135 4.5 21.8 1.0
O B:LEU1142 4.5 26.9 1.0
C B:ASP1133 4.5 32.1 1.0
OG B:SER1135 4.6 28.2 1.0
N B:ASP1133 4.6 32.3 1.0
CA B:PHE1134 4.6 27.4 1.0
N B:LEU1142 4.6 25.8 1.0
CB B:SER1141 4.7 20.9 0.5
CA B:ASP1133 4.8 35.0 1.0
O B:HOH58 4.8 21.8 1.0
CD B:LYS1132 4.8 35.3 1.0
CA B:SER1141 4.8 23.0 0.5
CA B:SER1141 4.9 20.7 0.5
O B:ASP1133 4.9 35.5 1.0

Reference:

J.Porter, S.Lumb, F.Lecomte, J.Reuberson, A.Foley, M.Calmiano, K.Le Riche, H.Edwards, J.Delgado, R.J.Franklin, J.M.Gascon-Simorte, A.Maloney, C.Meier, M.Batchelor. Discovery of A Novel Series of Quinoxalines As Inhibitors of C-Met Kinase. Bioorg.Med.Chem.Lett. V. 19 397 2009.
ISSN: ISSN 0960-894X
PubMed: 19059779
DOI: 10.1016/J.BMCL.2008.11.062
Page generated: Mon Oct 7 08:57:56 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy